INNOVATION

Discovery of cancer-specific target "Transglutaminase2"

COLLABORATION

Strategic Alliance for Strengthening Pipeline

BUSINESS

Licensing-out Business model after Clinical 2a

Ra, Sun Young(Non-Executive Director)

- Professor of Oncology, Yonsei University 

Kim, Tae Won(Non-Executive Director)

- Professor of Oncology,  Seoul Asan Hospital 

Jeong, Heon(Advisor)

- CEO at Aston Science 

Kim, Seonghwan(Advisor)

- Senior researcher of Korea Research Institute of Chemical Technology

Shin, Young Geun(Advisor)

- Professor of Chungnam National University College of Pharmacy 

Im, Seock Ah(Advisor)

- Professor of blood oncology, Seoul National University 

Park, Kyong Hwa(Advisor)

- Professor of hemato-oncology, Korea University Anam Hospital

Lee, Joo Seok
(Chief Executive Officer)

Kim, Sang Woo
(Chief Financial Officer)

Park, Jongho
(Management)

Jo, Yerin
(R&D Planning)

Jo, Eun E
(Research & Development)

Kim, HyunJoo
(Rearch & Planning)